• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Filaria in Ghana – Slideshow

Home > News

Filaria in Ghana – Slideshow

Dr. Linda Batsa Debrah examines Ama Dadiesa, 61, who has LF, causing swelling and "mossy" skin on her leg. Because of her condition, her husband divorced her and abandoned her and her children.
18 Jun 2014

Filaria is a group of neglected tropical diseases infecting over 150 million people in sub-Saharan Africa, Asia, and Latin America. The two main filarial diseases, onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis), devastate the lives of patients, causing debilitating symptoms and social discrimination. In March 2014, DNDi traveled to rural Ghana to meet and interview patients with filaria and the physician-researchers treating them.

River near Mankattah village, Dunkwa district, southern Ghana, an area endemic for onchocerciasis (river blindness). The black flies that transmit onchocerciasis are believed to breed in the river.
Setting up a medical examination tent in Mankattah village, Dunkwa district, southern Ghana, an area endemic for onchocerciasis (river blindness).
Medical research team from KCCR (Kumasi, Ghana), explaining the day’s activities to patients, Mankattah village. Speaking: Research Assistant Yusif Mubarik; seated: Prof. Achim Hoerauf (left), Dr. Alexander Debrah (right).
Dr. Alexander Debrah points to skin nodule on Kwame Michael Ntumi, 48, who has onchocerciasis. The nodule contains many adult filarial worms, which can live for 15 years.
Dr. Linda Batsa Debrah (left) with Gladys Bediako, 30, a patient with onchocerciasis from Mankattah village. Ms. Bediako suffers intense itching and body pain, often preventing her from working.
“Leopard skin” (discoloration of the skin) due to onchocerciasis is visible on these patients’ legs. This condition can cause social stigmatization and embarrassment for the patient.
View of Asemkow, a coastal village in Ghana, where lymphatic filariasis (LF, or elephantiasis) is endemic. Most of the people in Asemkow village make a living through catching and selling fish.
Dr. Linda Batsa Debrah examines Ama Dadiesa, 61, who has LF, causing swelling and “mossy” skin on her leg. Because of her condition, her husband divorced her and abandoned her and her children.
Adwoa Mamsowaa, 49, from the nearby village of Asemasa, has LF, causing massive swelling of her leg and recurrent attacks of body pain. When these attacks occur, she is not able to work.
Drawing blood to test for LF, in Asemkow village. Doctors use a rapid diagnostic immunochromatographic test (ICT) that can give a result in just a few hours.
Distribution of bowls and disinfectant soap to LF patients to wash and clean their limbs, to prevent infections.
Nighttime blood draw, Busua village, Ghana. Doctors examine the blood through a microscope to look for moving LF worms, which are most actively transmitted at night.
Lab technologists extracting DNA from filarial worms, at KCCR (Kumasi Centre for Collaborative Research in Tropical Medicine), Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.
Dr. Alexander Debrah, co-lead researcher of the Filariasis Project at KCCR (Kumasi, Ghana), examines a filarial worm sample in a microscope at the university’s parasitology lab.

All photos, credit ©: DNDi/Cosmos/Sylvain Cherkaoui

Policy advocacy River blindness

Read, watch, share

Loading...
Stories
16 Jul 2026

Annie Liang: How students’ advocacy helped bring mycetoma out of the shadows

Publications
16 Jul 2026

DNDi 2025 Annual Report

Laboratory of Medicinal and Computational Chemistry (LQMC), São Paulo University USP, São Carlos Campus, São Paulo Brazil.
Press releases
13 Jul 2026

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security 

Chepokarial Rubben attentively cares for her five-year-old son, Romanu Kiptoo, at the kala-azar ward of Kacheliba Sub-County Referral Hospital in West Pokot County, Kenya. She gently soothes him, offering comfort as he endures the painful treatment for kala-azar.
Press releases
13 Jul 2026

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Press releases
8 Jul 2026

Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India

Patricia, 44, from Area 44 in Lilongwe, Malawi, has lived with vision loss for 10 years following a late diagnosis of cryptococcal meningitis.
Stories
30 Jun 2026

Cryptococcal meningitis: Africa’s neglected HIV killer

News
29 Jun 2026

Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors 

Publications
29 Jun 2026

Advancing global health innovation through Europe-Africa collaboration

VIEW ALL

Help neglected patients

To date, we have delivered fourteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Youtube X-twitter Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license